TrialLancet (London, England)2020

Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.

Rebecca C Fitzgerald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.